c-Kit and c-kit mutations in mastocytosis and other hematological diseases

被引:102
作者
Boissan, M [1 ]
Feger, F [1 ]
Guillosson, JJ [1 ]
Arock, M [1 ]
机构
[1] Fac Pharm, Cellular & Mol Hematol Unit, UPRES EA 2509, F-75006 Paris, France
关键词
mast cell; mastocytosis; stem cell factor; mutation;
D O I
10.1002/jlb.67.2.135
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mast cells (MC) are tissue elements derived front hematopoietic stem cells. Their differentiation and proliferation processes are under the influence of cytokines, including one of utmost importance known as stem cell factor (SCF), SCF receptor is encoded by the protooncogene c-kit, belongs to the type III receptor tyrosine kinase subfamily, and is also expressed on other hematopoietic or non-hematopoietic cells. Ligation of c-kit receptor by SCF induces its dimerization, followed by induction of multiple intracellular signaling pathways leading to cell proliferation and activation, Mastocytosis, a relatively rare group of diseases characterized by accumulation of MC in various tissues, are found isolated or sometimes associated with other hematological malignancies in humans. Although the initial events leading to mastocytosis are not yet unraveled, alterations of the c-kit gene have been described. Particularly interesting are acquired mutations resulting in a constitutively activated receptor, possibly involved in the increased numbers of MC in tissues. For this reason, future strategies might be envisaged to target specifically the mutated c-kit and/or its intracellular signaling.
引用
收藏
页码:135 / 148
页数:14
相关论文
共 131 条
[1]  
ALAI M, 1992, J BIOL CHEM, V267, P18021
[2]   Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].
Amarante-Mendes, GP ;
Kim, CN ;
Liu, L ;
Huang, Y ;
Perkins, CL ;
Green, DR ;
Bhalla, K .
BLOOD, 1998, 91 (05) :1700-1705
[3]   MOLECULAR-CLONING OF MAST-CELL GROWTH-FACTOR, A HEMATOPOIETIN THAT IS ACTIVE IN BOTH MEMBRANE-BOUND AND SOLUBLE FORMS [J].
ANDERSON, DM ;
LYMAN, SD ;
BAIRD, A ;
WIGNALL, JM ;
EISENMAN, J ;
RAUCH, C ;
MARCH, CJ ;
BOSWELL, HS ;
GIMPEL, SD ;
COSMAN, D ;
WILLIAMS, DE .
CELL, 1990, 63 (01) :235-243
[4]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[5]   c-kit activating mutations and mast cell proliferation in human leukemia [J].
Beghini, A ;
Larizza, L ;
Cairoli, R ;
Morra, E .
BLOOD, 1998, 92 (02) :701-702
[6]  
Bellone G, 1997, J CELL PHYSIOL, V172, P1, DOI 10.1002/(SICI)1097-4652(199707)172:1<1::AID-JCP1>3.0.CO
[7]  
2-S
[8]   A NEW ACUTE TRANSFORMING FELINE RETROVIRUS AND RELATIONSHIP OF ITS ONCOGENE V-KIT WITH THE PROTEIN-KINASE GENE FAMILY [J].
BESMER, P ;
MURPHY, JE ;
GEORGE, PC ;
QIU, F ;
BERGOLD, PJ ;
LEDERMAN, L ;
SNYDER, HW ;
BRODEUR, D ;
ZUCKERMAN, EE ;
HARDY, WD .
NATURE, 1986, 320 (6061) :415-421
[9]   THE 4TH IMMUNOGLOBULIN DOMAIN OF THE STEM-CELL FACTOR-RECEPTOR COUPLES LIGAND-BINDING TO SIGNAL-TRANSDUCTION [J].
BLECHMAN, JM ;
LEV, S ;
BARG, J ;
EISENSTEIN, M ;
VAKS, B ;
VOGEL, Z ;
GIVOL, D ;
YARDEN, Y .
CELL, 1995, 80 (01) :103-113
[10]  
BLECHMAN JM, 1993, STEM CELLS, V11, P12